Please login to the form below
antimicrobial
This page shows the latest antimicrobial news and features for those working in and with pharma, biotech and healthcare.
IFPMA launches AMR Action Fund to tackle antimicrobial resistance
a bid to tackle growing antimicrobial resistance (AMR). ... is a part of the broader issue of antimicrobial resistance.
Latest news
-
FDA green lights study of phage-based drug for resistant infections
PhageBank will be the first antimicrobial to increase in spectrum with use – obviating obsolescence and the need for stewardship,” he added.
-
Modest meeting sees only two drugs recommended by CHMP
The CHMP recommended a marketing authorisation of Japanese pharma company Shionogi’s antimicrobial drug Fetcroja (cefiderocol) for the treatment of infections caused by Gram-negative organisms in adults with limited treatment
-
Researchers discover new antibiotic using AI
The research is particularly significant given the growing issue of antimicrobial and antibiotic resistance across the world. ... There are approximately 25, 000 deaths in Europe alone each year resulting from drug-resistant bacterial infections, with
-
Antibiotic biotech Melinta files for bankruptcy
There are still players in the antibiotic and antimicrobial filed, however – Japanese pharma Shionogi recently won FDA approval for its antimicrobial drug Fetroja, in the treatment of adults with complicated urinary
-
Shionogi scores FDA approval for new cUTI antibiotic
Pivotal new treatment for adults with complicated urinary tract infection. Japanese pharma Shionogi has won FDA approval for its antimicrobial drug Fetroja, in the treatment of adult patients with complicated urinary
More from news
Approximately 43 fully matching, plus 69 partially matching documents found.
Latest Intelligence
-
The global antibiotic crisis: a 2020 perspective
In the forward of the 2019 CDC report on the threat posed by antimicrobial resistance he said simply: ‘We need stop referring to a coming post-antibiotic era – it’s already ... The plan is the latest step towards the government’s broader 20-year
-
The role of women in science and technology
Then there’s Victoria Savage, head of biology at the Antimicrobial Resistance Centre, which is the UK’s only dedicated R&D facility for this critically important field of work.
-
Weirdos and misfits
antimicrobial resistance.
-
Tackling antimicrobial resistance on multiple fronts
With an estimated 25, 000 deaths in Europe alone and one person dying every 15 minutes in the US because of drug-resistant bacterial infections, antimicrobial resistance (AMR) is undoubtedly one ... latest World Bank report, Pulling Together to Beat
-
Evolution or revolution: the latest review of NICE methods
NICE has ruled out some areas this time around. They include genomic techniques and testing strategies, medical devices and diagnostics used to tackle antimicrobial resistance, as well as reviewing digital health
More from intelligence
Approximately 6 fully matching, plus 13 partially matching documents found.
Latest appointments
-
IFPMA names new communications director
and to enable government to meet ambitious goals such as universal health coverage, global health security and continued innovation in areas of high unmet health needs such as antimicrobial resistance.
-
Destiny Pharma appoints new CEO
Destiny Pharma has appointed Neil Clark as CEO as the Brighton, UK-based firm plans a phase IIb trial for its lead antimicrobial candidate.
-
New health ministers and re-appointments after reshuffle
Ellison, who reprises her role as the secretary for public health that she has held since 2013, also has a wide remit that includes pharma as will have responsibility for: antimicrobial
-
Xellia forms scientific advisory board
drugs to help tackle the global crisis of antimicrobial resistance.”. ... Antimicrobial resistance is a huge area of unmet medical need and one of the greatest threats to human health.
-
Cubist picks Robert Perez as its new CEO
area as the world recognises the growing threat of antimicrobial resistance.
More from appointments
Approximately 1 fully matching, plus 5 partially matching documents found.
Latest from PMHub
-
Antibiotic resistance: The silent pandemic
Up to 2 billion people, mainly in low- and middle-income countries, lack access to antimicrobials. ... Available at: https://www.healtheuropa.eu/antimicrobial-resistance/88272/. Accessed November 2019. World Health Organization. WHO global strategy for
-
Mobilising the public to combat the antimicrobial resistance crisis
Antimicrobial resistance is one of the greatest threats to human health, according to the World Health Organisation. ... Her illness is due to antimicrobial resistance (AMR) and it is not as rare as you might think.
-
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians navigating ... Antimicrobial resistance claims 5,
-
Antibiotic Resistance: Alarm bells ring louder than ever
where antibiotics and the threat of antimicrobial resistance (AMR) became a hot topic in the mainstream media. ... Another angle is the development of small molecules that can be administered in conjunction with antimicrobials to prevent resistance
-
Blue Latitude Health
Antimicrobial resistance is one of the greatest threats to human health, according to the World Health Organisation. ... Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial
More from PMHub
Approximately 0 fully matching, plus 5 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- China’s CanSino Biologics reveals phase 2 coronavirus vaccine results
- How will the events and exhibitions industry change post-Coronavirus?
- AbbVie, Roche’s Venclyxto combo reduces risk of death in first-line AML
- Novartis builds its case for novel MS treatment ofatumumab
- Russia becomes first country to approve a COVID-19 vaccine
- Tecentriq combo fails in advanced triple negative breast cancer
- UK agrees on COVID-19 vaccine deals with J&J and Novavax
- COVID-19 vaccine approval unlikely before November, says US NIH director
- Calliditas bets on PBC drug in Genkyotex buyout
- Emotion-driven clinical trial marketing: A missed opportunity?
- Speed kills
- Unleashing the Potential of Multichannel Digital Strategies in Healthcare
PMHub
claire@dovetailstrategies.com
About Dovetail We’re award-winning specialists in healthcare collaboration that makes patients’ lives better. Combining expertise with a passion for collaboration,...
Latest intelligence
- Emotion-driven clinical trial marketing: A missed opportunity?
- Whether we’re conscious of it or not, our emotions play a huge role in day-to-day decision making. Psychological scientists have long explored emotional influences on decision making. Experts like Herbert...
- Virtual Hackathon on Healthcare Innovation: a Customer Story
- How participants from 9 different countries in the APAC region were brought together to participate in a pharmaceutical company-wide 3-day virtual "hackathon," with spectacular results....
- OPEN Health at the World Orphan Drug Conference USA
- Our Director of Rare Disease, Gavin Jones looks forward to his conversation with Emily Crossle & Betsy Bogard at #WODCUSA2020 !...
Quick links
Infographics
